AIkido Pharma (AIKI) News Today $1.57 -0.06 (-3.68%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period SNOA Sonoma Pharmaceuticals, Inc.March 17, 2024 | seekingalpha.comRoyalty Pharma PLCJanuary 23, 2024 | wsj.comKengan Ashura: 10 Strongest Fighters, RankedOctober 6, 2023 | msn.comDominari Holdings Inc. Releases Shareholder UpdateSeptember 6, 2023 | markets.businessinsider.comKyle Wool Appears on Fox BusinessApril 10, 2023 | markets.businessinsider.comDominari Holdings Appoints George Way As CFOApril 3, 2023 | markets.businessinsider.comDominari Financial Inc. Acquires Leading Broker Dealer and Registered Investment Advisor BusinessMarch 27, 2023 | markets.businessinsider.comDominari Financial Granted Approval to Acquire Broker DealerMarch 21, 2023 | benzinga.comDominari Holdings Provides Business UpdateMarch 14, 2023 | finance.yahoo.comDominari Holdings Provides Update on Share Repurchase ProgramDecember 28, 2022 | finance.yahoo.comAIkido Pharma Inc.: AIkido Pharma Announces Successful Initial Public Offering of ASP IsotopesDecember 22, 2022 | finanznachrichten.deAIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH)December 22, 2022 | finance.yahoo.comAIkido Pharma Announces Successful Initial Public Offering of ASP IsotopesNovember 28, 2022 | finance.yahoo.comAIkido Share Repurchase ContinuesOctober 6, 2022 | finance.yahoo.comAIkido Purchases More SharesOctober 5, 2022 | finance.yahoo.comShare Repurchase Program ContinuesOctober 4, 2022 | finance.yahoo.comAIkido Pharma Continues Share Repurchase ProgramOctober 3, 2022 | finance.yahoo.comAIkido Pharma Provides Update on Share Repurchase ProgramSeptember 30, 2022 | finance.yahoo.comDominari Financial, Inc. Executes Definitive Agreement to Buy Broker-DealerSeptember 9, 2022 | prnewswire.comPre-Open Movers: Nielsen Climbs 20%, AppLivin Makes Offer for UnityAugust 10, 2022 | ca.investing.comAIkido Pharma Gets $8/Share Buyout Offer From Shalom Auerbach >AIKIAugust 10, 2022 | marketwatch.comAIkido Pharma Receives Offer From Shalom Auerbach - Quick FactsAugust 10, 2022 | nasdaq.comAIkido Pharma Confirms Receipt of Unsolicited OfferAugust 10, 2022 | finance.yahoo.comInvestor Makes Proposal to Acquire AIkido Pharma for $8.00 Per Share in CashAugust 9, 2022 | finance.yahoo.comAikido Pharma IncAugust 7, 2022 | reuters.comAIkido Pharma, Inc. Hires Carlos Aldavero to Lead Financial Services SubsidiaryJuly 21, 2022 | finance.yahoo.comAIkido Pharma regains Nasdaq complianceJune 30, 2022 | seekingalpha.comAIkido Inc. Announces the Formation of a New Financial Services SubsidiaryJune 24, 2022 | finance.yahoo.comSignificant Investor in AIkido Pharma Urges Board to Commit to Sell Assets and Return Capital to StockholdersJune 21, 2022 | finance.yahoo.comAIkido Pharma Inc. Appoints New Director, Soo YuJune 10, 2022 | finance.yahoo.comSignificant Investor in AIkido Pharma Issues Open...June 9, 2022 | benzinga.comAIkido Pharma stock falls again after reverse stock split takes effectJune 8, 2022 | morningstar.comSignificant Investor in AIkido Pharma Issues Open Letter to Board of DirectorsJune 7, 2022 | finance.yahoo.comWhy Is AIkido Pharma (AIKI) Stock Up 1,400%?June 7, 2022 | investorplace.comAIkido Pharma Approves Reverse Stock Split; Stock FallsJune 5, 2022 | marketwatch.comAlkido Pharma announces 1-for-17 reverse stock splitJune 3, 2022 | seekingalpha.comAIkido Announces Reverse Stock SplitJune 3, 2022 | finance.yahoo.comAIkido Pharma Announces Company Commitment to Board DiversityMay 19, 2022 | finance.yahoo.comAIkido Pharma Secures Interest in Databricks Inc.May 12, 2022 | finance.yahoo.comAIkido Pharma (NASDAQ:AIKI) Is In A Good Position To Deliver On Growth PlansMay 11, 2022 | finance.yahoo.comAIkido Reports Slinger Bag Inc.'s Filing for Nasdaq Public ListingMay 5, 2022 | finance.yahoo.comAIkido Pharma Announces Strategic Investment in Social Communications Platform Provider Discord, Inc.May 4, 2022 | finance.yahoo.comGlass Lewis Proxy Paper Report Recommends 'FOR' AIkido Pharma Proposed Reverse Stock SplitApril 24, 2022 | benzinga.comGlass Lewis Proxy Paper Report Recommends "FOR" AIkido Pharma Inc. Proposed Reverse Stock SplitApril 22, 2022 | prnewswire.com5 Penny Stocks to Buy in AprilApril 7, 2022 | insidermonkey.comAikido Pharma Announces Strategic Investment In MasterClass; Terms Not DisclosedApril 5, 2022 | benzinga.comAIkido Pharma Reports Strategic Investment In MasterClass, No Terms DisclosedApril 5, 2022 | benzinga.comAIkido Pharma Announces Strategic Investment in MasterClassApril 5, 2022 | finance.yahoo.comTrading was temporarily halted for "AIKI" at 02:04 PM with a stated reason of "LULD pause." Trading set to resume at 02:04 PM. April 5, 2022 | marketbeat.comAIkido Pharma to Co-Fund, Develop Cancer Treatment With Cedars-Sinai Medical CenterMarch 11, 2022 | marketwatch.com Get AIkido Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AIKI and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide AIKI Media Mentions By Week AIKI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AIKI News Sentiment▼0.000.47▲Average Medical News Sentiment AIKI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AIKI Articles This Week▼00▲AIKI Articles Average Week Get AIkido Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AIKI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Xcel Brands News OneMedNet News bioAffinity Technologies News FOXO Technologies News iSpecimen News Research Frontiers News Acacia Research News IQVIA News ICON Public News Incyte News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AIKI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIkido Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIkido Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
